Elliott J - Search Results

1

Identification of endothelin receptor subtypes in rat kidney cortex using subtype-selective ligands.

Nambi P, Wu HL, Pullen M, Aiyar N, Bryan H, Elliott J. Nambi P, et al. Among authors: elliott j. Mol Pharmacol. 1992 Aug;42(2):336-9. Mol Pharmacol. 1992. PMID: 1325032

2

Nonpeptide endothelin receptor antagonists. VII: Binding characteristics of [3H]SB 209670, a novel nonpeptide antagonist of endothelin receptors.

Nambi P, Pullen M, Wu HL, Lee D, Saunders D, Heys R, Aiyar N, Leber J, Elliott J, Brooks D, Ohlstein E, Ruffolo R. Nambi P, et al. Among authors: elliott j. J Pharmacol Exp Ther. 1996 Jun;277(3):1567-71. J Pharmacol Exp Ther. 1996. PMID: 8667224

3

The selective endothelin ETA receptor antagonist BQ123 antagonizes endothelin-1-mediated mitogenesis.

Ohlstein EH, Arleth A, Bryan H, Elliott JD, Sung CP. Ohlstein EH, et al. Among authors: elliott jd. Eur J Pharmacol. 1992 Apr 10;225(4):347-50. doi: 10.1016/0922-4106(92)90109-9. Eur J Pharmacol. 1992. PMID: 1323478

4

Nonpeptide endothelin receptor antagonists. I. Effects on binding and signal transduction on human endothelinA and endothelinB receptors.

Nambi P, Elshourbagy N, Wu HL, Pullen M, Ohlstein EH, Brooks DP, Lago MA, Elliott JD, Gleason JG, Ruffolo RR Jr. Nambi P, et al. Among authors: elliott jd. J Pharmacol Exp Ther. 1994 Nov;271(2):755-61. J Pharmacol Exp Ther. 1994. PMID: 7965793

5

Nonpeptide endothelin receptor antagonists. II. Pharmacological characterization of SB 209670.

Ohlstein EH, Beck GR Jr, Douglas SA, Nambi P, Lago MA, Gleason JG, Ruffolo RR Jr, Feuerstein G, Elliott JD. Ohlstein EH, et al. Among authors: elliott jd. J Pharmacol Exp Ther. 1994 Nov;271(2):762-8. J Pharmacol Exp Ther. 1994. PMID: 7965794

6

Nonpeptide endothelin receptor antagonists. III. Effect of SB 209670 and BQ123 on acute renal failure in anesthetized dogs.

Brooks DP, dePalma PD, Gellai M, Nambi P, Ohlstein EH, Elliott JD, Gleason JG, Ruffolo RR Jr. Brooks DP, et al. Among authors: elliott jd. J Pharmacol Exp Ther. 1994 Nov;271(2):769-75. J Pharmacol Exp Ther. 1994. PMID: 7965795

7

Pharmacologic characterization of the novel, orally available endothelin-A--selective antagonist SB 247083.

Douglas SA, Nambi P, Gellai M, Luengo JI, Xiang JN, Brooks DP, Ruffolo RR Jr, Elliott JD, Ohlstein EH. Douglas SA, et al. Among authors: elliott jd. J Cardiovasc Pharmacol. 1998;31 Suppl 1:S273-6. doi: 10.1097/00005344-199800001-00077. J Cardiovasc Pharmacol. 1998. PMID: 9595458

8

SB 234551, a novel endothelin--A receptor antagonist, unmasks endothelin-induced renal vasodilatation in the dog.

Brooks DP, DePalma PD, Pullen M, Elliott JD, Ohlstein EH, Nambi P. Brooks DP, et al. Among authors: elliott jd. J Cardiovasc Pharmacol. 1998;31 Suppl 1:S339-41. doi: 10.1097/00005344-199800001-00094. J Cardiovasc Pharmacol. 1998. PMID: 9595475

9

Nonpeptide endothelin receptor antagonists. V: Prevention and reversal of acute renal failure in the rat by SB 209670.

Gellai M, Jugus M, Fletcher T, Nambi P, Ohlstein EH, Elliott JD, Brooks DP. Gellai M, et al. Among authors: elliott jd. J Pharmacol Exp Ther. 1995 Oct;275(1):200-6. J Pharmacol Exp Ther. 1995. PMID: 7562550

10

1,3-Diarylindan-2-carboxylic acids, potent and selective non-peptide endothelin receptor antagonists.

Elliott JD, Lago MA, Cousins RD, Gao A, Leber JD, Erhard KF, Nambi P, Elshourbagy NA, Kumar C, Lee JA, et al. Elliott JD, et al. J Med Chem. 1994 May 27;37(11):1553-7. doi: 10.1021/jm00037a003. J Med Chem. 1994. PMID: 8201588 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,092 results

Search Page

Filters